Guidelines for the diagnosis and treatment of pulmonary hypertension

被引：864

作者：

Galie, N. ^{[1
]}

Hoeper, M. M. ^{[2
]}

Humbert, M. ^{[3
]}

Torbicki, A. ^{[4
]}

Vachiery, J-L. ^{[5
]}

Barbera, J. A. ^{[6
]}

Beghetti, M. ^{[7
]}

Corris, P. ^{[8
]}

Gaine, S. ^{[9
]}

Gibbs, J. S. ^{[10
]}

Gomez-Sanchez, M. A. ^{[11
]}

Jondeau, G. ^{[12
]}

Klepetko, W. ^{[13
]}

Opitz, C. ^{[14
]}

Peacock, A. ^{[15
]}

Rubin, L.

Zellweger, M. ^{[16
]}

Simonneau, G. ^{[17
,18
]}

机构：

[1] Bologna Univ Hosp, Inst Cardiol, I-40138 Bologna, Italy

[2] Hannover Med Sch, Dept Pulm Med, Hannover, Germany

[3] Hop Antoine Beclere, Serv Pneumol & Reanimat Resp, Clamart, France

[4] Inst Lung Dis & TB, Dept Chest Med, Warsaw, Poland

[5] Univ Libre Bruxelles, Hop Erasme, Dept Cardiol, Brussels, Belgium

[6] Hosp Clin Barcelona, Serv Pneumol, Barcelona, Spain

[7] Hop Enfants, Unite Cardiopediat, Geneva, Switzerland

[8] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England

[9] Mater Misericordiae Univ Hosp, Pulm Hypertens Unit, Dublin, Ireland

[10] Hammersmith Hosp, Dept Cardiol, London, England

[11] Hosp Doce Octubre, Dept Microbiol, Madrid, Spain

[12] Hop Bichat Claude Bernard, Serv Cardiol, F-75877 Paris, France

[13] Med Univ Vienna, Div Cardiothorac Surg, Vienna, Austria

[14] DRK Kliniken Berlin Kopenick, Dept Internal Med Cardiol, Berlin, Germany

[15] Univ Glasgow, Western Infirm, Scottish Pulm Vasc Unit, Glasgow G11 6NT, Lanark, Scotland

[16] Univ Hosp, Dept Cardiol, Basel, Switzerland

[17] Hop Antoine Beclere, Dept Pneumol, Clamart, France

[18] Hop Antoine Beclere, ICU, Clamart, France

来源：

EUROPEAN RESPIRATORY JOURNAL | 2009年 / 34卷 / 06期

关键词：

LONG-TERM TREATMENT; CONTINUOUS INTRAVENOUS EPOPROSTENOL; BRAIN NATRIURETIC PEPTIDE; CALCIUM-CHANNEL BLOCKERS; CHRONIC HEART-FAILURE; 6-MINUTE WALK TEST; QUALITY-OF-LIFE; ARTERIAL-HYPERTENSION; INHALED ILOPROST; BOSENTAN THERAPY;

D O I：

10.1183/09031936.00139009

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：1219 / 1263

页数：45

共 260 条

[11] Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease -: A randomized, controlled trial [J].

Badesch, DB ;

Tapson, VF ;

McGoon, MD ;

Brundage, BH ;

Rubin, LJ ;

Wigley, FM ;

Rich, S ;

Barst, RJ ;

Barrett, PS ;

Kral, KM ;

Jöbsis, MM ;

Loyd, JE ;

Murali, S ;

Frost, A ;

Girgis, R ;

Bourge, RC ;

Ralph, DD ;

Elliott, CG ;

Hill, NS ;

Langleben, D ;

Schilz, RJ ;

McLaughlin, VV ;

Robbins, IM ;

Groves, BM ;

Shapiro, S ;

Medsger, TA ;

Gaine, SP ;

Horn, E ;

Decker, JC ;

Knobil, K .

ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) :425-+

[12] Highly active antiretroviral therapy compared with HAART and bosentan in combination in patients with HIV-associated pulmonary hypertension [J].

Barbaro, G. ;

Lucchini, A. ;

Pellicelli, A. M. ;

Grisorio, B. ;

Giancaspro, G. ;

Barbarini, G. .

HEART, 2006, 92 (08) :1164-1166

[13] Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease [J].

Barbera, JA ;

Roger, N ;

Roca, J ;

Rovira, I ;

Higenbottam, TW ;

RodriguezRoisin, R .

LANCET, 1996, 347 (8999) :436-440

[14] Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil [J].

Barst, R. J. ;

Galie, N. ;

Naeije, R. ;

Simonneau, G. ;

Jeffs, R. ;

Arneson, C. ;

Rubin, L. J. .

EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (06) :1195-1203

[15] Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension [J].

Barst, RJ ;

Ivy, D ;

Dingemanse, J ;

Widlitz, A ;

Schmitt, K ;

Doran, A ;

Bingaman, D ;

Nguyen, N ;

Gaitonde, M ;

van Giersbergen, PLM .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (04) :372-382

[16] Diagnosis and differential assessment of pulmonary arterial hypertension [J].

Barst, RJ ;

McGoon, M ;

Torbicki, A ;

Sitbon, O ;

Krowka, MJ ;

Olschewski, H ;

Gaine, S .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) :40S-47S

[17] Sitaxsentan therapy for pulmonary arterial hypertension [J].

Barst, RJ ;

Langleben, D ;

Frost, A ;

Horn, EM ;

Oudiz, R ;

Shapiro, S ;

McLaughlin, V ;

Hill, N ;

Tapson, VF ;

Robbins, IM ;

Zwicke, D ;

Duncan, B ;

Dixon, RAF ;

Frumkin, LR .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (04) :441-447

[18] Vasodilator therapy for primary pulmonary hypertension in children [J].

Barst, RJ ;

Maislin, G ;

Fishman, AP .

CIRCULATION, 1999, 99 (09) :1197-1208

[19] A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension [J].

Barst, RJ ;

Rubin, LJ ;

Long, WA ;

McGoon, MD ;

Rich, S ;

Badesch, DB ;

Groves, BM ;

Tapson, VF ;

Bourge, RC ;

Brundage, BH ;

Koerner, SK ;

Langleben, D ;

Keller, CA ;

Murali, S ;

Uretsky, BF ;

Clayton, LM ;

Jobsis, MM ;

Blackburn, SD ;

Shortino, D ;

Crow, JW .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :296-301

[20] Beraprost therapy for pulmonary arterial hypertension [J].

Barst, RJ ;

McGoon, M ;

McLaughlin, V ;

Tapson, V ;

Oudiz, R ;

Shapiro, S ;

Robbins, IM ;

Channick, R ;

Badesch, D ;

Rayburn, BK ;

Flinchbaugh, R ;

Sigman, J ;

Arneson, C ;

Jeffs, R .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (12) :2119-2125

← 1 2 3 4 5 6 7 8 9 10 →